Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01175668 · ClinicalTrials.gov registry record · NA
Clonidine for Neonatal Abstinence Syndrome Study
A NA study, sponsored by Baystate Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT01175668 is a NA study that was terminated before completion, run by Baystate Medical Center. The registered enrollment target is 68 participants.
The verdict
NCT01175668, a NA study, was terminated before completion, sponsored by Baystate Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
The study plans to compare the use of Clonidine versus Phenobarbital as an additional medication to neonatal morphine sulfate for treatment of newborn infants undergoing drug withdrawal symptoms due to mother's use of opioid drug use. The investigators hypothesis is that use of Clonidine will lead to shorter duration of treatment, hospital stay and thereby early discharge home.
Interventions
- DRUG Clonidine
- DRUG Phenobarbital
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2010-07 |
| Est. Completion | 2012-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01175668
The ClinicalTrials.gov registry entry for NCT01175668 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baystate Medical Center, which has 36 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Clonidine is the first listed.
NCT01175668 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01175668 about?
NCT01175668 is a clinical study titled "Clonidine for Neonatal Abstinence Syndrome Study". The study plans to compare the use of Clonidine versus Phenobarbital as an additional medication to neonatal morphine sulfate for treatment of newborn infants undergoing drug withdrawal symptoms due to mother's use of opioid drug use. The investigators hypothesis is that use of Clonidine will lead t...
What is the current status of trial NCT01175668?
This trial is currently terminated. It is a NA study. The enrollment target is 68 participants. The study started on 2010-07. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01175668?
The interventions under investigation include: Clonidine (DRUG), Phenobarbital (DRUG).
Who is sponsoring clinical trial NCT01175668?
This trial is sponsored by Baystate Medical Center, which has 36 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.